Reports indicate that the induction of IDO limits the severity of experimental IBD [45], while inhibition of IDO augments T helper 1 cell (Th1)-mediated trinitrobenzene sulfonic acid (TNBS) colitis [46] underscoring the regulatory impact of IDO on gastrointestinal immune responses. Here, IDO1 is linked to inflammatory bowel disease.